Patents Assigned to Janssen Diagnotics, LLC
  • Patent number: 9134237
    Abstract: A sample of blood containing CTCs, or other cells of interest, is stained with fluorescent markers for image analysis and scanned to identify the presence and location within the cartridge of target cells or subcellular elements. A sample containing desired target cells or subcellular elements is then further processed, in part by photobleaching the sample, so that those same targets may be re-analyzed with additional biomarkers conjugated to the same or different fluorochromes using the same imaging criteria that were used for the initial analysis. The present invention has applications with targets such as circulating epithelial, cells, circulating tumor cells, circulating endothelial cells, leukocytes, lymphocyte subsets, cells containing an organelle or receptor of interest, cellular debris, disrupted cells and their debris, or any other formed element that might be captured and imaged.
    Type: Grant
    Filed: July 29, 2008
    Date of Patent: September 15, 2015
    Assignee: Janssen Diagnotics, LLC
    Inventors: Mark Carle Connelly, Frank Coumans, Steve Gross, Mike Kelly